Journal of Viral Hepatitis

Article	Citations
Issue Information	104
Issue Information	32
	28
Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study	26
Issue Information	24
Clinical Observational Study on HBV Reactivation After Direct‐Acting Antiviral Therapy in HCV /	23
Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine	23
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B	22
Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐19	20
240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C	20
The role of serum sphingolipids as potential biomarkers of non‐response to direct acting antiviral therapy in chronic hepatitis C virus infection	20
Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab	19
Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England	19
Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review	19
Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination	18
Uptake of the Birth Dose HBV Vaccine and Associated Factors Among Children in Sub‐Saharan Africa: An Analysis Using Recent Demographic and Health Survey Data	18
Issue Information	18
International disease burden of acute viral hepatitis among adolescents and young adults: An observational study	18
A cross‐sectional study of hepatitis C prevalence and correlates among persons who inject drugs in rural and non‐rural communities	18
Extrahepatic carcinogenicity of oral nucleos(t)ide analogues in chronic hepatitis B carriers: A 35,000‐Korean outcome study	17
Infectivity of Hepatitis B Virus Surface Antigen‐Positive Plasma With Undetectable HBV‐DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood Donors?	17
Elevation of S2‐bound α1‐acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma	17
Sex‐related difference analyses of efficacy and safety in clinical trials of direct‐acting antivirals to treat chronic HCV genotype 1 and 3 infections	16
Reversibility of acute‐on‐chronic liver failure syndrome in hepatitis B virus‐infected patients with and without prior decompensation	16
Long‐Term Follow‐Up of Neuropsychiatric Symptoms After Sustained Virological Response to Interferon‐Free and Interferon‐Based Hepatitis C Virus Treatment	15

TRPM2 regulates autophagy to participate in hepatitis B virus replication	15
Evaluation of Blood Droplet Volumes on the Cobas Plasma Separation Card for HCV RNA Testing in Resource‐Limited Settings	15
A Network Map of Intracellular Alpha‐Fetoprotein Signalling in Hepatocellular Carcinoma	15
Contribution of alcohol use in HIV/hepatitis C virus co‐infection to all‐cause and cause‐specific mortality: A collaboration of cohort studies	15
Trends and Socio‐Demographic Patterns of Hepatitis B Virus Hospitalisations in Poland: A 12‐Year Nationwide Analysis	14
Safe co‐administration of direct‐acting antivirals and direct oral anticoagulants among patients with hepatitis C virus infection: An international multicenter retrospective cohort study	13
Integration and the risk of liver cancer—Is there a real risk?	13
Issue Information	13
Characterisation of People Living With Chronic Hepatitis B Virus Infection in England and Stratification by HBsAg Levels: A Cross‐Sectional Study	13
Epidemiology and Outcomes of Hepatitis E Virus‐Associated Hospitalisations in the United States With a Focus on Pregnancy: A Nationwide Population Study, 1998–2020	13
Prevalence of Hepatitis B Among Migrants Living in High‐Income Countries With Low/Intermediate HBV Prevalence–A Systematic Review and Meta‐Analysis	13
Issue Information	12
Sustainable and equivalent improvements in symptoms and functional well‐being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection:	12
Clinical and histological features of patients with chronic hepatitis B virus infection in the grey zone	12
Serum HBV RNA is associated with liver fibrosis regression in HBeAg‐positive chronic hepatitis B patients treated with nucleos(t)ide analogues	12
The changing epidemiology of delta hepatitis in Türkiye over three decades: A systematic review	12
Strategies to increase primary care provider capacity for hepatitis C care: The California ECHO‐PLUS study	12
Network‐basedstrategies to combatHCV: Examining social and spatial drivers of transmission amongPWIDin New Delhi	12
Systematic Screening for Hepatitis B, C, and HIV and Linkage to Care in Patients With Mental Health Disorders Admitted to the Emergency Department	12
	12
Challenges of hepatitis B treatment in rural Sub‐Saharan Africa: Treatment initiation and outcomes from a public hospital‐based clinic in Kono, Sierra Leone	12
Baseline and on‐treatment HBcrAg levels as predictors of HBeAg seroconversion in chronic hepatitis B patients treated with antivirals	11
A declaration from people living with hepatitis B: A call for a whole person approach	11
	11
HCV hotline facilitates Hepatitis C elimination during the COVID‐19 pandemic	11
Risk of drug‐induced liver injury in chronic hepatitis B and tuberculosis co‐infection: A systematic review and meta‐analysis	10
Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good Option! The DEVICHO	10
Epidemiological Burden of Hepatitis Delta Virus in the United States	10
Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta‐analysis	10
Measuring stigma associated with hepatitis B virus infection in Sierra Leone: Validation of an abridged Berger HIV stigma scale	10
An updated assessment of hepatitis delta prevalence among adults in Canada: A meta‐analysis	10
Challenges of an EMR‐Based Hospital Alert Program for Micro‐Elimination of Hepatitis C in Tertiary Referral Hospitals	10
Hepatitis E prevalence and infection in solid‐organ transplant recipients in the United States	10
Outcomes and Survival of Egyptian Patients With Hepatitis B–Related Hepatocellular Carcinoma: A Multicentre Retrospective Study	10
Posttreatment nonalcoholic fatty liver disease fibrosis scores for predicting liver‐related complications in patients with chronic hepatitis C receiving direct‐acting antiviral agents	10
	9
Mixed‐Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis	9
The Efficacy and Sustainability of an Implementation Intervention ( FOCUS Program) on Linkage to Hepatitis C Care Time at a Community Health Center i	9
Dynamic personalized prediction of the individual liver‐related risk after sustained viral response in HCV patients	9
The role of treatment of hepatitis C with direct‐acting antiviral agents on glycaemic control in diabetic patients: An updated systematic review and meta‐analysis	9
Hepatitis D virus infection: Progress on the path toward disease control and cure	9
Frequency, Severity and Impact of Pegylated Interferon Alpha–Associated Flares in Hepatitis D Infection	9
Viral hepatitis in pregnancy	9
Prognostic value of genotyping in hepatocellular carcinoma: A systematic review	9
Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather)	9
Duration of Nucleos(t)ide Analogue Treatments in Patients With Chronic Hepatitis B Virus Infection in the United States	8
Associations Between Prior and Current Unhealthy Alcohol Use and Liver Morbidity Risk and Mortality Among Veterans With a History of Hepatitis C Who Have Achieved Sustained Virological Response	8
CHB patients with rtA181T‐mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes	8
Performance of HCV core antigen and PCR testing in a predominantly genotype 3 population	8
Does hepatitis delta virus have a preference for hepatitis B virus genotype? A systematic review of the literature	8

The immune landscape in hepatitis delta virus infection—Still an open field	8
Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™	8
Hepatitis B Vaccination Uptake and Associated Factors in the United States Before Implementing Universal Vaccination: A Nationally‐Representative Study	8
Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi‐ethnic population: Universal screening is more comprehensive	8
Hepatitis B e antigen and e antibody in a multi‐ethnic cohort of adult chronic hepatitis B virus patients followed at a single liver unit for a period of 20 years	8
Issue Information	7
	7
Phase 1 study of safety and tolerability of an oral contraceptive containing low‐dose ethinyl oestradiol combined with glecaprevir/pibrentasvir treatment in healthy premenopausal women	7
A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C Programmes in Prisons	7
Impact of COVID‐19 lockdown restrictions on hepatitis C testing in Australian primary care services providing care for people who inject drugs	7
Screening rates for hepatitis B and C among low‐income US veterans: Data from the National Veteran Homeless and Other Poverty Experiences Study	7
Kinetics changes in total cholesterol predict HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon‐alfa	7
Role of hepatitis B surface antibody in seroreversion of hepatitis B surface antigen in patients achieving hepatitis B surface antigen loss with pegylated interferon‐based therapy	7
Performance Evaluation of the Elecsys HCV Duo Immunoassay in the Public Healthcare Setting in Cape Town, South Africa	7
	7
Preferences and feasibility of long‐acting technologies for treatment of hepatitis C virus in low‐ and middle‐income countries: A survey of providers and policymakers	7
Impact of hepatitis C treatment status on risk of Parkinson's disease and secondary parkinsonism in the era of direct‐acting antivirals	7
Barriers and enablers to people‐centred viral hepatitis care in Vietnam and the Philippines: Results of a patient journey mapping study	7
A novel test and treat program for hepatitis C virus infection utilizing HCV core antigen testing, among police and general population, Islamabad, Pakistan, 2022	7
Risk factors for hepatitis C virus infection at a large urban emergency department	7
	7
Balancing Efficiency and Accuracy in Hepatitis C Rapid Antibody Testing: Insights From a Cluster Randomised Crossover Trial	7
Hepatitis Delta Coinfection Rates and All‐Cause Mortality Among Hepatitis B‐Infected Veterans in the USA	7
MELD score < 18 rule out 28‐day ACLF development among inpatients with hepatitis B‐related previous compensated liver disease	7
Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis	7
The Impact of Ambient Temperature on HCC Risk in Patients With Chronic Hepatitis B	7
Mortality and morbidity related to hepatitis C virus infection in hospitalized adults—A propensity score matched analysis	7
MiRNome Profiling of Circulating Extracellular Vesicles in Patients With Chronic Hepatitis D Undergoing Pegylated Interferon Alpha Treatment	6
Issue Information	6
Substance use and CD4/CD8 ratio in HIV/HCV co‐infected people receiving direct‐acting antiviral treatment (ANRS CO13 HEPAVIH)	6
Severe acute hepatitis of unknown origin in children: Is it still a mystery? What role does adenovirus play?	6
The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection	6
A Programme of Hepatitis C Surveillance With Active Linkage to Care (HEAL) for Inpatients in Two Tertiary Hospitals in Jiangsu, China	6
Persistence of antibodies 5 years after hepatitis B vaccination in preterm birth children: A retrospective cohort study using real‐world data	6
Hepatocytes and Hepatic Stellate Cells Carry Different Levels of DNA Damage due to Their Sensitivity to Oxidative Stress in Chronic Hepatitis B	6
Identifying and Linking to Care and Treatment Persons With Hepatitis C Who Were Lost to Follow‐Up, Georgia 2023–2024	6
Outcomes of Assisted Reproductive Technology in Women With Hepatitis B Infection	6
Reply to ‘Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial’	6
Association Between Indirect Bilirubin Percentage to Albumin Ratio and Outcome of Hepatitis B Related Acute on Chronic Liver Failure Treated With Artificial Liver Support System	6
Comments on “Hepatitis B Virus ( HBV ) Treatment Eligibility in the UK : Retrospective Longitudina	6
Recognisable Alcohol Use Significantly Increases the Risk of Adverse Outcomes in Patients With Hepatitis B Virus‐Related Cirrhosis	6
Prevalence of hepatitis B virus (HBV) and latent tuberculosis co‐infection and risk of drug‐induced liver injury across two large HBV cohorts in the United	6
	6
Early clinical efficacy of pegylated interferon treatment in patients with different phases of chronic HBV infection: A real‐world analysis	6
Cigarette Smoking Is Associated With Lower Chance of Hepatitis B Surface Antigen Seroclearance and Altered Host Immunity	6
Issue Information	6
Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C Virologic Cure	6
Knowledge and Perceptions of Hepatitis B in Immigrant Populations: A Systematic Review and Thematic Synthesis of Qualitative Research	6
Screening, Prevalence and Management of Chronic Viral Hepatitis C in Mental Health Setting: Towards the Eradication of A Forgotten Reservoir	6
Closing the hepatitis C treatment gap: United States strategies to improve retention in care	6
A morphometric analysis of hepatitis B subviral particles shows no correlation of filament proportion and length with clinical stage and genotype	6
	6
Sequence characterization of extracellular HBV RNA in patient plasma	6
Hepatitis after gene therapy, what are the possible causes?	5
Depletion of circ_0088046 suppressed cell growth and motility of hepatocellular carcinoma via circ_0088046‐miR‐1299‐RTKN2 ceRNA pathway	5
Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A Longitudinal Study Following DAA Therapy	5
Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus Infection With Interferon or Direct Antiviral Therapy	5
Prevalence of hepatitis C among pregnant women in an Appalachian population	5
Chronic viral hepatitis C micro‐elimination program using telemedicine in Guigang city	5
Factors influencing compliance with Hepatitis C treatment in patients transitioning from prison to community—A summary scoping review	5
HBV pgRNA profiles in Chinese HIV/HBV coinfected patients under pre‐ and posttreatment: a multicentre observational cohort study	5
Hepatitis C prevalence and elimination planning in Pakistan, a bottom‐up approach accounting for provincial variation	5
Outcomes of a 1‐Year Pilot Study Implementing Universal Hepatitis Delta Virus Testing Among Veterans With Chronic Hepatitis B	5
	5
	5
Issue Information	5
Time to Hepatitis C Care Engagement and Treatment Outcomes in Canadian Immigrants Have Markedly Improved Over Three Decades	5
Substance use and CD4/CD8 ratio in HIV/HCV co‐infected people receiving direct‐acting antiviral treatment (ANRS CO13 HEPAVIH): Authors' reply	5
Telemedicine for Low‐Barrier Hepatitis C Care in Rural Patients With Substance Use Disorders: Lessons From Taiwan	5
Hepatic Steatosis Inhibits Hepatitis B Virus Replication by Promoting miR ‐122‐5p‐ SOX4	5
Prevalence and Factors Associated With Hepatitis B Virus Infection in Tigray Region, Northern Ethiopia	5
Genetic substructure and host‐specific natural selection trend across vaccine‐candidate ORF‐2 capsid protein of hepatitis‐E virus	5
Lower Serum Albumin Level: A Prospective Risk Predictor of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection	5
Impact of Universal Screening for HDV in HBV‐ Infected Patients on Chronic	5
Impact of Non‐Alcoholic Fatty Liver Disease on the HBsAg Loss of Patients With Chronic Hepatitis B Treated in Pegylated Interferon Alpha	5
	4
Issue Information	4
Regarding the predictive role of CXCL16 in liver inflammation in chronic hepatitis B patients	4
Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update	4
Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID‐19 pandemic	4

Cost‐Effectiveness of De Novo Combination of Tenofovir Alafenamide Fumarate and Peginterferon Alfa‐2b Versus Peginterferon Alfa‐2b Monotherapy of HBeAg	4
Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States	4
Towards hepatitis C elimination in France: Scanvir, an effective model to test and treat drug users on dedicated days	4
Test characteristics for combining non‐invasive liver fibrosis staging modalities in individuals with Hepatitis C virus	4
Hepatitis C active viremia over time in an ED‐based testing programme: Impact, disparities and surveillance tool	4
Issue Information	4
Hepatitis B Care and Treatment in Zanzibar, Tanzania: A Demonstration Project Following 2015 WHO Treatment Guidelines, 2017–2021	4
Community Pop‐Up Clinic: Cascade of Care and HCV Treatment of Vancouver's Inner‐City PWID Populations	4
Protective Role of Coffee in Chronic Liver Disease: A Focus on Processing	4
	4
Shear wave elastography: How well does it perform in chronic hepatitis D virus infection?	4
Testing to sustain hepatitis C elimination targets in people who inject drugs: A network‐based model	4
Efficacy and safety of pan‐genotypic sofosbuvir and velpatasvir in patients with hepatitis C and HIV coinfection on dolutegravir‐based antiretroviral therapy	4
Trends in Use of Direct‐Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016–2024	4
Reply to: ‘Abnormal liver function tests and coronavirus disease 2019: A close relationship’	4
Comparison of acknowledged hepatocellular carcinoma risk scores in high‐risk hepatitis C patients with sustained virological response	4
	4
	4
A randomized phase 1b trial of the active site polymerase inhibitor nucleotide ATI‐2173 in patients with chronic hepatitis B virus infection	4
Determining the frequency and characteristics of Hepatitis C reinfections in North East England	4
Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial	4
Impact of treatment with direct‐acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co‐infected individuals	4
Prevalence and determinants of hepatitis delta virus infection among HIV/hepatitis B‐coinfected adults in care in the United States	4
Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment	4
Demographic and Clinical Characteristics of Patients With Hepatitis C and Hepatitis B Co‐Infection, Georgia, 2017–2023	4
Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradication	3
Changes in the prevalence of hepatitis B and C viral infections in Sindh province, Pakistan: Findings from two sero‐surveys in 2007 and 2019	3
Antiviral therapy response in patients with chronic hepatitis B and fatty liver: A systematic review and meta‐analysis	3
Epidemiology, linkage to care and natural history of women of childbearing age with chronic hepatitis B: A population‐based study	3
Methodological Considerations in Prevalence Meta‐Analysis of Hepatitis B Among Migrants	3
Unhealthy Behaviours and All‐Cause Mortality Among People With Chronic Hepatitis B, With and Without Hepatitis Delta ( ANRS CO22 HEPATHER )	3
Hepatitis C virus‐specific immune responses following direct‐acting antivirals administered during recent hepatitis C virus infection	3
	3
Chronic hepatitis C virus infections in Switzerland in 2020: Lower than expected and suggesting achievement of WHO elimination targets	3
Impact of prior HBV, HAV, and HEV infection on non‐alcoholic fatty liver disease	3
Response to “Reply to ‘Assessing the hepatitis C epidemiology in Switzerland: It’s not that trivial’”	3
Human Herpesvirus 6 in Acute Liver Failure: Leading Role, Supporting Actor or Innocent Bystander? A Case Series, Narrative Review and Management Algorithm Proposal	3
Non‐Specialist Physicians Successfully Treat Hepatitis C Infection With Simplified Care Pathway in France	3
Issue Information	3
Immunotherapy Using HBV Vaccine Pulsed DCs and Induced T‐Cells Combined Antiviral Drugs in Treatment Naive CHB Patients‐A Multi‐Centre Phase II Study	3
Targeted Screening for Hepatitis B: Insights From Hong Kong and Implications for Endemic Regions	3
Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of Cardiometabolic Risk Factors	3
Hepatitis C care cascade before and during the direct‐acting antiviral eras in New South Wales, Australia: A population‐based linkage study	3
Automated electronic health registry‐based hepatitis B screening	3
Early post‐liver transplant use of direct‐acting antivirals in naive and NS5A inhibitor‐experienced HCV patients	3
Prescriber Specialty Involvement in Medicare Patients With Chronic Hepatitis B	3
Accuracy of International Guidelines in Identifying Normal Liver Histology in Chinese Patients With HBeAg‐Positive Chronic HBV Infection	3
Comparison of HBV DNA and RNA markers in Alaska Native people who did and did not clear hepatitis B surface antigen	3
Real‐World Evaluation of Point‐of‐Care Testing for Hepatitis C Antibodies: Navigating Hepatitis C Elimination Effort	3
A Health Systems Strengthening Approach to Address the High Burden of Hepatitis C in Pakistan	3
	3
	3
Evaluating the cost‐effectiveness of hepatitis B vaccination strategies in high‐impact settings for adults	3
Expanding Hepatitis C Virus Treatment in the New Mexico State Prison System: Using the ECHO Model for Provider and Prison Peer Education	3
Bridging the Gap: How Distance to Hospitals Limits HCV Treatment Initiation in France	3
Issue Information	3
	3
MicroRNA‐206 inhibits HCV proliferation through depressing ACC1 lipid synthesis signalling pathway	3
Prognosis of Acute HEV Infection in Patients With Liver Cirrhosis: A Retrospective Study of 628 Chinese Patients	3
U‐Shaped Relationship Between CT‐Measured Liver‐To‐Spleen Volume Ratio and Mortality in HBV‐ACLF Patients	3
Racial discrimination, knowledge, and health outcomes: The mediating role of hepatitis B‐related stigma among patients with chronic hepatitis B	3
Updated Guidelines for the Prevention and Management of Chronic Hepatitis B—World Health Organization 2024 Compared With China 2022 HBV Guidelines	3
Cover Image	3
Significance of serum HBV RNA in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients who discontinue effective antiviral therapy	3
Evaluation of a pilot emergency department linkage to care program for patients previously diagnosed with Hepatitis C	3
Incidence of primary hepatitis C infection among people who inject drugs during 2012–2020 in Athens, Greece	3
Characteristics of Newly Reported Chronic Hepatitis C Cases Among Adults in the United States, 2016–2023: Insights From Population‐Based Surveillance	2
	2
	2
Cost‐Effectiveness of Interventions to Improve Retention in Care for Chronic Hepatitis B in the United States	2
Geographic variation in HCV treatment penetration among people who inject drugs in Baltimore, MD	2
Early Read‐Time Performance of the OraQuick HCV Rapid Antibody Assay for the Exclusion of HCV Viremia	2
A novel non‐invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD	2
Misuse of the Lower Limit of Detection in HBV DNA Testing and Anti‐HBe Positive Status Will Significantly Impact the Diagnosis of Occult HBV Infection	2
Single‐Cell Transcriptome Identifies a Proinflammatory B‐Cell Subset in Hepatitis B Virus Associated Acute‐on‐Chronic Liver Failure	2
	2
What is the impact of a Hepatitis C ‘test, trace and treat’ pilot using peer workers?	2
Hepatitis B Virus in Jordan: Prevalence, Incidence and Clearance From Cross‐Sectional and Cohort Studies	2
	2
The complex, confusing and poorly understood immune responses to AAV‐mediated gene transfer in haemophilia—Is more or less immunosuppression required?	2
Abnormal liver function tests and coronavirus disease 2019: A close relationship	2
Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian community	2
More intensive hepatitis C virus care models promote adherence among people who inject drugs with active drug use: The PREVAIL study	2
Epidemiology and Control of Widespread Community Hepatitis A Outbreaks in 37 U.S. States, 2016–2023	2
Prognosis of hepatitis E infection in patients with chronic liver disease: A meta‐analysis	2
A US‐Based Multi‐Site Pilot to Screen Hepatitis B Surface Antigen‐Positive Patients for Hepatitis D	2
Scoping Review on Strategies for Safe Nucleot(s)ide Analogue Discontinuation and Optimising Functional Cure in Chronic Hepatitis B	2
Impact of Concurrent Steatotic Liver Disease and Chronic Hepatitis B on Treatment Response to Nucleos(t)ide Analogs	2
Low‐Barrier Fibrosis Screening in Hepatitis C Treatment: The Decompensated Cirrhosis in Hepatitis C Evaluation Questionnaire	2
Issue Information	2
Safety, pharmacokinetics and antiviral activity of ABI‐H2158, a hepatitis B virus core inhibitor: A randomized, placebo‐controlled phase 1 study	2
Research progress on detection methods for hepatitis B virus covalently closed circular DNA	2
Chronic hepatitis B beyond clinical burden: Psychosocial effects and impact on quality of life	2
	2
	2